Invention Grant
- Patent Title: Ribonucleic acid (RNA) interactions
-
Application No.: US16300664Application Date: 2017-05-12
-
Publication No.: US11597968B2Publication Date: 2023-03-07
- Inventor: Yue Wan , Jong Ghut Ashley Aw , Niranjan Nagarajan , Andreas Wilm , Miao Sun
- Applicant: Agency for Science, Technology and Research
- Applicant Address: SG Singapore
- Assignee: Agency for Science, Technology and Research
- Current Assignee: Agency for Science, Technology and Research
- Current Assignee Address: SG Singapore
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: SG10201603786V 20160512
- International Application: PCT/SG2017/050254 WO 20170512
- International Announcement: WO2017/196264 WO 20171116
- Main IPC: C12Q1/6869
- IPC: C12Q1/6869 ; C12Q1/6806 ; C40B50/00

Abstract:
The invention relates to a method for analysing ribonucleic acid (RNA) interactions comprising: a) cross-linking base-paired nucleotides of at least one RNA molecule and/or at least one pair of RNA molecules using a tagged, reversible cross-linking agent (preferably tagged-psoralen) under ultraviolet irradiation; b) fragmenting the said cross-linked RNA molecule(s); c) using said tag to extract said cross-linked RNA fragment(s); d) ligating the said cross-linked RNA fragment(s) to produce cross-linked ligated RNA chimera(s); e) reversing the cross-linking of the said agent to the said RNA molecule(s); f) preparing a sequence library by sequencing the ligated RNA chimera molecule(s) or pair(s); and g) analysing the sequence library to determine RNA interactions. Also disclosed is a method of studying a subject by analysing RNA interactions and attributing them to a clinical picture, or a drug discovery method by attributing an efficacy score to the drug based upon determined RNA interactions.
Public/Granted literature
- US20190284622A1 RIBONUCLEIC ACID (RNA) INTERACTIONS Public/Granted day:2019-09-19
Information query